Jonathan Roach
Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatoblastoma | 9 | 2026 | 52 | 2.330 |
Why?
| | Liver Neoplasms | 13 | 2026 | 787 | 1.930 |
Why?
| | Biliary Atresia | 6 | 2022 | 163 | 1.730 |
Why?
| | Medical Errors | 2 | 2025 | 119 | 1.330 |
Why?
| | Surgical Oncology | 8 | 2026 | 30 | 1.220 |
Why?
| | Specialties, Surgical | 2 | 2022 | 84 | 1.180 |
Why?
| | Pancreatic Neoplasms | 2 | 2026 | 947 | 1.020 |
Why?
| | Neoplasm Recurrence, Local | 8 | 2026 | 1166 | 1.010 |
Why?
| | Adrenal Cortex Neoplasms | 2 | 2025 | 70 | 0.990 |
Why?
| | Adrenocortical Carcinoma | 2 | 2025 | 72 | 0.980 |
Why?
| | Hepatectomy | 2 | 2026 | 280 | 0.970 |
Why?
| | Pancreatectomy | 2 | 2026 | 290 | 0.950 |
Why?
| | Echinococcosis | 1 | 2026 | 9 | 0.940 |
Why?
| | Kidney Neoplasms | 7 | 2026 | 421 | 0.940 |
Why?
| | Liver Transplantation | 6 | 2024 | 841 | 0.900 |
Why?
| | Laparoscopy | 4 | 2026 | 486 | 0.890 |
Why?
| | Carcinoma, Papillary | 1 | 2025 | 83 | 0.870 |
Why?
| | Child | 46 | 2026 | 22980 | 0.830 |
Why?
| | Appointments and Schedules | 1 | 2025 | 97 | 0.830 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 124 | 0.770 |
Why?
| | Survival Rate | 11 | 2026 | 2110 | 0.760 |
Why?
| | Robotic Surgical Procedures | 1 | 2026 | 207 | 0.750 |
Why?
| | Surgeons | 3 | 2026 | 342 | 0.750 |
Why?
| | Child, Preschool | 24 | 2026 | 12017 | 0.680 |
Why?
| | Infant | 24 | 2026 | 10195 | 0.680 |
Why?
| | Portoenterostomy, Hepatic | 3 | 2022 | 43 | 0.670 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2024 | 379 | 0.610 |
Why?
| | Choledocholithiasis | 3 | 2025 | 20 | 0.610 |
Why?
| | Gallstones | 3 | 2025 | 35 | 0.610 |
Why?
| | Neoplasms | 5 | 2026 | 2946 | 0.580 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 163 | 0.580 |
Why?
| | Pediatrics | 3 | 2025 | 1139 | 0.560 |
Why?
| | Retrospective Studies | 30 | 2026 | 17561 | 0.540 |
Why?
| | Cholestasis | 1 | 2020 | 217 | 0.520 |
Why?
| | Adolescent | 27 | 2026 | 22826 | 0.510 |
Why?
| | Quality Improvement | 2 | 2025 | 1321 | 0.490 |
Why?
| | Wilms Tumor | 3 | 2023 | 90 | 0.470 |
Why?
| | Indocyanine Green | 2 | 2026 | 43 | 0.470 |
Why?
| | Appendectomy | 3 | 2023 | 92 | 0.460 |
Why?
| | Patient Safety | 1 | 2019 | 356 | 0.440 |
Why?
| | Adrenalectomy | 2 | 2025 | 68 | 0.440 |
Why?
| | Teratoma | 2 | 2026 | 124 | 0.440 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 357 | 0.430 |
Why?
| | Humans | 59 | 2026 | 147306 | 0.430 |
Why?
| | Nephrectomy | 4 | 2026 | 172 | 0.430 |
Why?
| | Postoperative Complications | 5 | 2026 | 3022 | 0.420 |
Why?
| | Accidents | 1 | 2014 | 46 | 0.410 |
Why?
| | Pancreaticoduodenectomy | 2 | 2026 | 149 | 0.410 |
Why?
| | MicroRNAs | 1 | 2020 | 695 | 0.400 |
Why?
| | Appendicitis | 2 | 2023 | 153 | 0.400 |
Why?
| | Digestive System Diseases | 1 | 2013 | 28 | 0.390 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 78 | 0.370 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2023 | 56 | 0.370 |
Why?
| | Abdomen | 1 | 2013 | 142 | 0.360 |
Why?
| | Sarcoma | 3 | 2024 | 210 | 0.350 |
Why?
| | Child Abuse | 2 | 2014 | 558 | 0.340 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 600 | 0.330 |
Why?
| | Internship and Residency | 1 | 2022 | 1279 | 0.330 |
Why?
| | Kidney Transplantation | 1 | 2017 | 732 | 0.320 |
Why?
| | Ovarian Neoplasms | 2 | 2026 | 599 | 0.310 |
Why?
| | Organ Transplantation | 1 | 2013 | 258 | 0.310 |
Why?
| | Tissue Donors | 1 | 2013 | 427 | 0.300 |
Why?
| | Bile Ducts | 2 | 2020 | 68 | 0.290 |
Why?
| | Brain Injuries | 1 | 2014 | 508 | 0.290 |
Why?
| | Blood Substitutes | 1 | 2009 | 27 | 0.290 |
Why?
| | Neoplasm Staging | 4 | 2026 | 1492 | 0.280 |
Why?
| | Inflammation | 1 | 2020 | 2921 | 0.280 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 76 | 0.280 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2025 | 223 | 0.270 |
Why?
| | Female | 28 | 2026 | 80081 | 0.270 |
Why?
| | Male | 26 | 2026 | 73954 | 0.260 |
Why?
| | Abdominal Abscess | 1 | 2007 | 28 | 0.260 |
Why?
| | Cellulitis | 1 | 2007 | 54 | 0.260 |
Why?
| | United States | 6 | 2026 | 16313 | 0.250 |
Why?
| | Cytokines | 2 | 2018 | 2087 | 0.240 |
Why?
| | Drainage | 1 | 2007 | 189 | 0.240 |
Why?
| | Endodermal Sinus Tumor | 1 | 2026 | 10 | 0.240 |
Why?
| | Hemoglobins | 1 | 2009 | 386 | 0.240 |
Why?
| | Lung Neoplasms | 3 | 2026 | 2679 | 0.240 |
Why?
| | Conversion to Open Surgery | 1 | 2026 | 22 | 0.230 |
Why?
| | Abdominal Neoplasms | 1 | 2026 | 48 | 0.230 |
Why?
| | Metastasectomy | 1 | 2026 | 19 | 0.230 |
Why?
| | Liver | 3 | 2026 | 1916 | 0.230 |
Why?
| | Optical Imaging | 1 | 2026 | 63 | 0.230 |
Why?
| | Fertility Preservation | 1 | 2026 | 57 | 0.230 |
Why?
| | Esophageal Atresia | 1 | 2026 | 32 | 0.230 |
Why?
| | Sentinel Lymph Node | 1 | 2026 | 49 | 0.230 |
Why?
| | Tracheoesophageal Fistula | 1 | 2026 | 40 | 0.220 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 12 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2791 | 0.220 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2026 | 117 | 0.220 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 863 | 0.220 |
Why?
| | Operative Time | 1 | 2026 | 195 | 0.220 |
Why?
| | Carcinoma, Medullary | 1 | 2025 | 16 | 0.220 |
Why?
| | Intraoperative Care | 1 | 2025 | 63 | 0.220 |
Why?
| | Length of Stay | 3 | 2026 | 1371 | 0.220 |
Why?
| | Rhabdoid Tumor | 1 | 2026 | 102 | 0.210 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.210 |
Why?
| | Soft Tissue Neoplasms | 1 | 2026 | 133 | 0.210 |
Why?
| | Databases, Factual | 3 | 2026 | 1504 | 0.210 |
Why?
| | Clinical Protocols | 1 | 2026 | 284 | 0.210 |
Why?
| | Pancreatitis | 1 | 2025 | 147 | 0.210 |
Why?
| | Mesenteric Veins | 1 | 2024 | 28 | 0.210 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2025 | 192 | 0.200 |
Why?
| | Infant, Newborn | 7 | 2026 | 6543 | 0.200 |
Why?
| | Pancreas | 1 | 2026 | 345 | 0.200 |
Why?
| | Appendiceal Neoplasms | 1 | 2023 | 28 | 0.190 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2023 | 16 | 0.190 |
Why?
| | Sarcoma, Ewing | 1 | 2024 | 103 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 76 | 0.190 |
Why?
| | Counseling | 1 | 2026 | 407 | 0.190 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2023 | 32 | 0.190 |
Why?
| | Combined Modality Therapy | 4 | 2026 | 1281 | 0.180 |
Why?
| | Follow-Up Studies | 7 | 2026 | 5478 | 0.180 |
Why?
| | Documentation | 1 | 2024 | 204 | 0.180 |
Why?
| | Treatment Outcome | 6 | 2026 | 11947 | 0.180 |
Why?
| | Prognosis | 6 | 2026 | 4384 | 0.180 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2022 | 25 | 0.180 |
Why?
| | Blood Transfusion | 1 | 2025 | 412 | 0.180 |
Why?
| | Registries | 2 | 2025 | 2434 | 0.180 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2022 | 23 | 0.180 |
Why?
| | Academic Medical Centers | 1 | 2025 | 566 | 0.170 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 123 | 0.170 |
Why?
| | Bone Neoplasms | 1 | 2024 | 272 | 0.170 |
Why?
| | Young Adult | 7 | 2026 | 14437 | 0.160 |
Why?
| | CD79 Antigens | 1 | 2020 | 16 | 0.160 |
Why?
| | Thoracic Wall | 1 | 2020 | 22 | 0.160 |
Why?
| | Thoracic Neoplasms | 1 | 2020 | 40 | 0.160 |
Why?
| | Cell Line | 2 | 2020 | 2832 | 0.160 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 27 | 0.150 |
Why?
| | Age Factors | 2 | 2025 | 3372 | 0.150 |
Why?
| | Hepatocytes | 1 | 2020 | 224 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 1431 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 112 | 0.140 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 212 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2026 | 865 | 0.140 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1220 | 0.130 |
Why?
| | Scoliosis | 1 | 2020 | 229 | 0.130 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 499 | 0.130 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6164 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2024 | 741 | 0.120 |
Why?
| | Critical Pathways | 1 | 2018 | 111 | 0.120 |
Why?
| | Clinical Competence | 1 | 2025 | 1260 | 0.120 |
Why?
| | Job Satisfaction | 1 | 2019 | 238 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2020 | 731 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2024 | 1214 | 0.120 |
Why?
| | Postoperative Care | 1 | 2018 | 299 | 0.120 |
Why?
| | Perioperative Care | 1 | 2017 | 231 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 31 | 0.100 |
Why?
| | Disease-Free Survival | 2 | 2026 | 779 | 0.100 |
Why?
| | Choledochal Cyst | 1 | 2013 | 17 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4605 | 0.100 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 63 | 0.100 |
Why?
| | Lymph Node Excision | 2 | 2025 | 173 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2020 | 3153 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1167 | 0.090 |
Why?
| | Patient Selection | 1 | 2017 | 746 | 0.090 |
Why?
| | Bilirubin | 2 | 2023 | 102 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2018 | 878 | 0.090 |
Why?
| | Forecasting | 1 | 2014 | 391 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 180 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2625 | 0.080 |
Why?
| | Preoperative Care | 1 | 2013 | 381 | 0.080 |
Why?
| | Time Factors | 3 | 2018 | 7173 | 0.080 |
Why?
| | Mice | 3 | 2020 | 18493 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1518 | 0.080 |
Why?
| | Protoporphyrins | 1 | 2009 | 16 | 0.070 |
Why?
| | Enzyme Induction | 1 | 2009 | 88 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 117 | 0.070 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 93 | 0.070 |
Why?
| | Adult | 5 | 2025 | 41406 | 0.070 |
Why?
| | Prospective Studies | 3 | 2026 | 8166 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 11 | 0.070 |
Why?
| | Aged | 2 | 2025 | 26516 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2007 | 46 | 0.060 |
Why?
| | Lymph | 1 | 2007 | 31 | 0.060 |
Why?
| | Colorado | 2 | 2014 | 4591 | 0.060 |
Why?
| | alpha-Fetoproteins | 1 | 2026 | 42 | 0.060 |
Why?
| | Middle Aged | 2 | 2025 | 36821 | 0.060 |
Why?
| | Coloring Agents | 1 | 2026 | 90 | 0.060 |
Why?
| | Margins of Excision | 1 | 2026 | 54 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 2026 | 30 | 0.060 |
Why?
| | Animals | 4 | 2020 | 38417 | 0.060 |
Why?
| | Fluorescence | 1 | 2026 | 161 | 0.060 |
Why?
| | Tuberous Sclerosis | 1 | 1986 | 56 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 589 | 0.060 |
Why?
| | Thoracoscopy | 1 | 2026 | 60 | 0.060 |
Why?
| | North America | 1 | 2026 | 307 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 822 | 0.060 |
Why?
| | Cholecystectomy | 1 | 2025 | 61 | 0.050 |
Why?
| | Shock, Hemorrhagic | 1 | 2007 | 200 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2024 | 15 | 0.050 |
Why?
| | Lymphatic Metastasis | 1 | 2026 | 338 | 0.050 |
Why?
| | Pylorus | 1 | 2024 | 17 | 0.050 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 41 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2024 | 88 | 0.050 |
Why?
| | Enteral Nutrition | 1 | 2026 | 218 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2026 | 975 | 0.050 |
Why?
| | Remission Induction | 1 | 2024 | 310 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 347 | 0.050 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 2023 | 3 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2023 | 86 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Lipase | 1 | 2023 | 76 | 0.050 |
Why?
| | Nephrons | 1 | 2022 | 23 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2023 | 151 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 177 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2023 | 66 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 90 | 0.050 |
Why?
| | Lymphoma | 1 | 2024 | 253 | 0.050 |
Why?
| | Thyroidectomy | 1 | 2023 | 96 | 0.050 |
Why?
| | Methylene Blue | 1 | 2022 | 24 | 0.040 |
Why?
| | Kidney Diseases | 1 | 1986 | 428 | 0.040 |
Why?
| | Patient Readmission | 1 | 2007 | 777 | 0.040 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2022 | 56 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1093 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 474 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 914 | 0.040 |
Why?
| | Universities | 1 | 2003 | 453 | 0.040 |
Why?
| | Risk-Taking | 1 | 2003 | 325 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1049 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 514 | 0.040 |
Why?
| | Markov Chains | 1 | 2020 | 132 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 475 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1342 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 534 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2003 | 502 | 0.040 |
Why?
| | Students | 1 | 2003 | 659 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 171 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1940 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 367 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 509 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 849 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2889 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 443 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 375 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 915 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1266 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2892 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 695 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1386 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2026 | 6011 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1172 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1730 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 2001 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2013 | 61 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 323 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1379 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2142 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2231 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 3246 | 0.020 |
Why?
| | Mesentery | 1 | 2007 | 44 | 0.020 |
Why?
| | Rupture, Spontaneous | 1 | 1986 | 15 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 1986 | 30 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 156 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 369 | 0.010 |
Why?
| | Actins | 1 | 2007 | 428 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2007 | 728 | 0.010 |
Why?
| | Midwestern United States | 1 | 2003 | 45 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2542 | 0.010 |
Why?
| | Contraception | 1 | 2003 | 170 | 0.010 |
Why?
| | Sexually Transmitted Diseases | 1 | 2003 | 168 | 0.010 |
Why?
| | Proteomics | 1 | 2007 | 1205 | 0.010 |
Why?
| | School Health Services | 1 | 2003 | 222 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 652 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5613 | 0.010 |
Why?
|
|
Roach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|